Posts

Breast RT: Coronary Artery Dose Better Predicts Cardiac Risk

For patients who receive heart-sparing radiotherapy for breast cancer, coronary artery dose is key in the risk for future cardiac events. Medscape Medical News source https://www.medscape.com/viewarticle/breast-rt-coronary-artery-dose-better-predicts-cardiac-risk-2026a1000mli?src=rss

Psoriasis: Can Gut Biotics Improve Treatment?

Emerging evidence suggests that gut biotics may help reduce inflammation and improve psoriasis severity, but larger studies are still needed before routine clinical use. Medscape News Europe source https://www.medscape.com/viewarticle/psoriasis-can-gut-biotics-improve-treatment-2026a1000mha?src=rss

Tirzepatide Weight Loss Greater in Women vs Men, Age No Link

In adults with overweight or obesity using tirzepatide for at least 12 months, women lost more weight, but age was not a predictor. Medscape Medical News source https://www.medscape.com/viewarticle/tirzepatide-weight-loss-greater-women-vs-men-age-no-link-2026a1000mh5?src=rss

Prescribing in Limited SSc: Who Gets Immunosuppression?

Prescribing practices for immunosuppressive therapy in limited cutaneous systemic sclerosis vary among rheumatologists, especially when managing skin or subclinical organ involvement. Medscape Medical News source https://www.medscape.com/viewarticle/prescribing-limited-cutaneous-systemic-sclerosis-who-gets-2026a1000maf?src=rss

Do HIV, Organ Transplant Raise Odds of HPV-Related Cancers?

A study evaluates whether people with HIV infection and solid organ transplant recipients have higher odds of HPV-related cancers than unexposed control individuals. Medscape Medical News source https://www.medscape.com/viewarticle/do-hiv-organ-transplant-raise-odds-hpv-related-cancers-2026a1000ma6?src=rss

Fecal Transplant Offers No Clear Benefit in IBS

Fecal microbiota transplantation offers no clear benefit in reducing symptoms of irritable bowel syndrome, a meta-analysis finds. Medscape Medical News source https://www.medscape.com/viewarticle/fecal-transplant-offers-no-clear-benefit-patients-ibs-2026a1000m3y?src=rss